(Q38053739)

27 August 2017

title

Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? (English)

1 reference

27 August 2017

0 references

Rabies virus

1 reference

5

1 reference

27 August 2017

Daniel L Horton

2

0 references

Anthony R. Fooks

series ordinal

4

object named as

Anthony R Fooks

1 reference

27 August 2017

Jennifer S Evans

1

1 reference

27 August 2017

Andrew J Easton

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

19 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

52

1 reference

27 August 2017

page(s)

7447-7454

1 reference

The challenge of new and emerging lyssaviruses

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Rabies encephalitis in malaria-endemic area, Malawi, Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

The feasibility of canine rabies elimination in Africa: dispelling doubts with data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Passive immunity in the prevention of rabies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

A reliable diagnosis of human rabies based on analysis of skin biopsy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

European bat Lyssavirus transmission among cats, Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Human rabies of bat origin in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Australian bat lyssavirus infection: a second human case, with a long incubation period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Novel lyssaviruses isolated from bats in Russia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Quantifying antigenic relationships among the lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Antibodies against Lagos bat virus in megachiroptera from West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Shimoni bat virus, a new representative of the Lyssavirus genus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Complete genome sequence of Ikoma lyssavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Efficacy of rabies biologics against new lyssaviruses from Eurasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Rabies virus glycoprotein is a trimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Vaccines for lyssaviruses other than rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

First encounter of European bat lyssavirus type 2 (EBLV-2) in a bat in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Sequence analysis of an isolate from a fatal human infection of Australian bat lyssavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Fatal human infection with rabies-related Duvenhage virus, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Deduced structural model for animal rhabdovirus glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Chimeric lyssavirus glycoproteins with increased immunological potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.10.015

1 reference

27 August 2017

1 reference